๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Experience with the clinical development of influenza vaccines for potential pandemics

โœ Scribed by J. Wood; K. Nicholson; I. Stephenson; M. Zambon; R. Newman; D. Major; A. Podda

Publisher
Springer-Verlag
Year
2002
Tongue
English
Weight
309 KB
Volume
191
Category
Article
ISSN
0300-8584

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The development of live attenuated cold-
The development of live attenuated cold-adapted influenza virus vaccine for humans
โœ Hunein F. Maassab; Martin L. Bryant ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 1 views

A procedure to attenuate live influenza virus of type A and type B was developed using adaptation of the virus to grow at 25 degrees C (cold adaptation; ca). Through a series of stepwise passages, two stable mutants were obtained and designated as 'Master' strains, one for type A influenza virus (A/

Development and comparison of molecular
Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus
โœ Wai-Yip Lam; Ting-Fan Leung; Nelson Lee; Jo L.K. Cheung; Apple C.M. Yeung; Yolan ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 1 views

## Abstract Human infection with the novel pandemic influenza A (H1N1) virus was first identified in April 2009. Two months later, the World Health Organization (WHO) had raised the pandemic level to phase 6. Rapid case identification is essential for prompt patient management and public health act